<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2872</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJCRR.2020.121726</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Coronavirus Disease (COVID) 2019 in Children __ampersandsignndash; a Short Review&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lohiya</surname><given-names>Sham Balkisanji</given-names></name></contrib><contrib contrib-type="author"><name><surname>Damke</surname><given-names>Sachin</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chaudhary</surname><given-names>Richa</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>8</day><month>09</month><year>2020</year></pub-date><volume>7)</volume><issue/><fpage>172</fpage><lpage>177</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a series of Cases of severe pneumonia worldwide. It originated in Wuhan in Hubei province, China. SARS-CoV-2 causes infection by ACE receptors, similar to SARS. It causes potential damage to vital organs, mainly the lungs. COVID- 19 mainly affects respiratory tract with symptoms ranging from upper respiratory tract infection like symptoms to full-blown ARDS. Although the pediatric age group is shown to be less susceptible to severe infection, they can very well act as an intermediate in the transmitter of the virus. Treatment is symptomatic for mild diseases, but severe disease and ARDS require ICU management and specific treatment.&#13;
</p></abstract><kwd-group><kwd>COVID 19</kwd><kwd> Neonate</kwd><kwd> Pediatrics</kwd><kwd> Suspetible</kwd><kwd> Treatment</kwd></kwd-group></article-meta></front></article>
